News
November 2022 – The Data Driven Point of View

November 2022 – The Data Driven Point of View

Problem:   Understanding Polygenic Risk Scores (PRS) clinical utility and limitations can be a significant challenge. Solution:   An evaluation of clinical evidence and laboratory validation data will assist you in identifying the most accurate and clinically...

read more
July 2022 – The Data Driven Point of View Special Edition Interview Newsletter:  Justin Zook, Ph.D., Co-Leader, Biomarker & Genetic Sciences Group; National Institute of Standards and Technology (NIST)

July 2022 – The Data Driven Point of View Special Edition Interview Newsletter: Justin Zook, Ph.D., Co-Leader, Biomarker & Genetic Sciences Group; National Institute of Standards and Technology (NIST)

Center For Genomic Interpretation (CGI) is very excited to share the interview edition of our monthly newsletter.  Justin Zook, Ph.D. is the Co-Leader of Biomarker and Genomic Sciences Group at the National Institute of Standards and Technology (NIST).  In the...

read more
August 2022 – The Data Driven Point of View

August 2022 – The Data Driven Point of View

Problem:   What exactly is a physician’s role and responsibility when testing patients for genetic abnormalities?   The American College of Physicians (ACOP) recently released a position paper discussing just this issue. Precision medicine raises many issues...

read more
September 2022 – The Data Driven Point of View

September 2022 – The Data Driven Point of View

Problem:   How can YOU maximize value in precision medicine?  Is precision medicine truly precise?   The American Journal of Clinical Pathology recently published an article stating that only 37% of NGS oncology clinical labs reported ALL important mutations in their...

read more
October 2022 – The Data Driven Point of View

October 2022 – The Data Driven Point of View

Problem:   There are systematic problems with accuracy in CLINICAL GENETICS & GENOMICS.   Also, accustomed to self-policing, the genetics and genomics lab community express concerns about quality threshold requirements from insurance payors.  This thinking and...

read more